Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
22.90
Dollar change
0.00
Percentage change
0.00
%
Index- P/E- EPS (ttm)-11.33 Insider Own39.74% Shs Outstand20.34M Perf Week-19.96%
Market Cap587.38M Forward P/E- EPS next Y-3.02 Insider Trans1.48% Shs Float15.46M Perf Month-40.52%
Income-57.15M PEG- EPS next Q-0.67 Inst Own37.15% Short Float4.29% Perf Quarter-19.25%
Sales0.00M P/S- EPS this Y67.59% Inst Trans-7.46% Short Ratio1.89 Perf Half Y-20.21%
Book/sh10.08 P/B2.27 EPS next Y-4.90% ROA-28.29% Short Interest0.66M Perf Year29.38%
Cash/sh7.91 P/C2.89 EPS next 5Y- ROE-29.68% 52W Range9.18 - 48.31 Perf YTD-12.53%
Dividend Est.- P/FCF- EPS past 5Y-19.23% ROI-27.85% 52W High-52.60% Beta2.36
Dividend TTM- Quick Ratio41.76 Sales past 5Y0.00% Gross Margin- 52W Low149.46% ATR (14)3.81
Dividend Ex-Date- Current Ratio41.76 EPS Y/Y TTM36.78% Oper. Margin0.00% RSI (14)29.92 Volatility9.87% 9.16%
Employees52 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price58.33
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q81.92% Payout- Rel Volume1.92 Prev Close22.90
Sales Surprise- EPS Surprise-14.41% Sales Q/Q- EarningsMar 19 BMO Avg Volume351.13K Price22.90
SMA20-39.03% SMA50-37.74% SMA200-18.46% Trades Volume674,912 Change0.00%
Date Action Analyst Rating Change Price Target Change
Dec-15-23Initiated Jefferies Buy $41
Dec-04-23Resumed H.C. Wainwright Buy $48
Nov-17-23Initiated Truist Buy $43
Oct-31-23Initiated Guggenheim Buy $50
Oct-25-23Initiated Piper Sandler Overweight $65
Oct-20-22Initiated H.C. Wainwright Buy $18
Jul-05-22Downgrade Morgan Stanley Overweight → Equal-Weight $20 → $8
Mar-19-24 02:52PM
07:00AM
Mar-15-24 08:50AM
Feb-28-24 08:50AM
Feb-27-24 07:30AM
08:50AM Loading…
Feb-08-24 08:50AM
Feb-01-24 08:00AM
Jan-29-24 04:01PM
Jan-25-24 07:00AM
Jan-24-24 04:05PM
Jan-08-24 07:00AM
Dec-15-23 04:00PM
Dec-14-23 07:30AM
Nov-01-23 08:00AM
Oct-26-23 09:02PM
05:37PM Loading…
Oct-19-23 05:37PM
Oct-17-23 05:47PM
Oct-06-23 05:09PM
Oct-04-23 08:30AM
Jun-22-23 07:30AM
May-26-23 07:00AM
May-20-23 08:18AM
Feb-16-23 03:10PM
07:00AM
Dec-25-22 09:25AM
Nov-22-22 07:00AM
Nov-10-22 07:00AM
Nov-07-22 07:00AM
Oct-21-22 11:28AM
Oct-20-22 02:27PM
10:26AM Loading…
10:26AM
08:24AM
07:00AM
Oct-17-22 07:00AM
Oct-04-22 07:00AM
Sep-21-22 07:00AM
Sep-06-22 07:00AM
Aug-15-22 07:00AM
Jul-18-22 09:47AM
Jun-30-22 07:00AM
Jun-07-22 04:01PM
Jun-01-22 07:00AM
May-31-22 07:00AM
May-17-22 04:01PM
07:00AM
May-12-22 04:01PM
May-02-22 07:00AM
Apr-28-22 11:45AM
Apr-06-22 04:01PM
Mar-22-22 04:01PM
Mar-17-22 04:01PM
Feb-11-22 07:00AM
Feb-08-22 01:32PM
Jan-31-22 09:38AM
Jan-06-22 07:00AM
Jan-04-22 07:00AM
Dec-20-21 07:00AM
Dec-14-21 07:00AM
Nov-30-21 07:00AM
Nov-12-21 07:00AM
Nov-08-21 07:00AM
Nov-04-21 06:00AM
Oct-29-21 07:00AM
Oct-28-21 04:36PM
Sep-02-21 07:00AM
Aug-12-21 07:00AM
Aug-10-21 08:10AM
Jun-14-21 04:01PM
Jun-03-21 07:00AM
May-11-21 04:01PM
May-06-21 09:53PM
Tourmaline Bio, Inc. is a late-stage clinical biotechnology company, which engages in the development of medicines for patients with life-altering immune diseases. It offers the TOUR006. The company was founded by Sandeep Kulkarni on September 17, 2021 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MCDADE MARKDirectorJan 29 '24Buy32.50100,0003,250,000448,431Jan 31 04:26 PM
Kulkarni Sandeep ChidambarCEONov 17 '23Buy16.994,00067,960729,735Nov 20 06:15 PM
Thiara ParvinderDirectorNov 17 '23Buy17.311,00017,31083,782Nov 20 06:14 PM
Castelein CaleyDirectorOct 27 '23Buy14.5515,800229,890516,519Oct 27 05:43 PM
Kulkarni Sandeep ChidambarCEOOct 26 '23Buy12.255,00061,250725,735Oct 26 05:34 PM
Castelein CaleyDirectorOct 25 '23Buy12.074,20050,694500,719Oct 27 05:43 PM
Thiara ParvinderDirectorOct 25 '23Buy12.122,00024,24082,782Oct 26 04:46 PM
KANTOFF AARONDirectorOct 24 '23Buy11.867,50088,95045,391Oct 26 05:00 PM
Thiara ParvinderDirectorOct 24 '23Buy10.665,00053,30080,782Oct 26 04:46 PM
Kulkarni Sandeep ChidambarCEOOct 24 '23Buy10.684,65049,662720,735Oct 26 05:34 PM
Ildstad SuzanneDirectorJun 14 '23Sale2.4912,94232,2443,771,392Jun 14 06:58 PM
Ildstad SuzanneDirectorJun 13 '23Sale2.5614,20836,3383,784,334Jun 14 06:58 PM
Ildstad SuzanneDirectorJun 12 '23Sale2.5916,87043,7253,798,542Jun 14 06:58 PM
Ildstad SuzanneDirectorJun 09 '23Sale2.4625,41962,6373,815,412Jun 09 05:41 PM
Ildstad SuzanneDirectorJun 08 '23Sale2.4840,642100,7723,840,831Jun 09 05:41 PM
Ildstad SuzanneDirectorJun 07 '23Sale2.3975,001179,0953,881,473Jun 09 05:41 PM
Ildstad SuzanneDirectorJun 06 '23Sale2.5325,54964,5962,756,474Jun 07 06:24 PM
Ildstad SuzanneDirectorJun 05 '23Sale2.527,84119,7552,782,023Jun 07 06:24 PM
Ildstad SuzanneDirectorJun 02 '23Sale2.5015,81839,6162,789,864Jun 05 04:21 PM
Ildstad SuzanneDirectorJun 01 '23Sale2.5615,71340,1772,805,682Jun 05 04:21 PM
Ildstad SuzanneDirectorApr 21 '23Sale2.3515,00435,2312,821,395Apr 25 05:50 PM
Ildstad SuzanneDirectorApr 20 '23Sale2.3346,990109,3132,836,399Apr 21 07:57 AM
Ildstad SuzanneDirectorApr 19 '23Sale2.1621,75347,0562,883,389Apr 21 07:57 AM
Ildstad SuzanneDirectorApr 18 '23Sale2.1549,211105,8042,905,142Apr 19 09:22 AM
Ildstad SuzanneDirectorApr 17 '23Sale2.1499,771213,5302,954,353Apr 19 09:22 AM